Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
---|---|---|---|---|---|---|---|---|---|
Patent 10961187 was granted and assigned to Promentis Pharmaceuticals on March, 2021 by the United States Patent and Trademark Office. | 10961187 | March 30, 2021 | |||||||
Patent 9457014 was granted and assigned to Promentis Pharmaceuticals on October, 2016 by the United States Patent and Trademark Office. | 9457014 | October 4, 2016 | |||||||
Patent 8624052 was granted and assigned to Promentis Pharmaceuticals on January, 2014 by the United States Patent and Trademark Office. | 8624052 | January 7, 2014 | |||||||
Patent 10358414 was granted and assigned to Promentis Pharmaceuticals on July, 2019 by the United States Patent and Trademark Office. | 10358414 | July 23, 2019 | |||||||
Patent 9630937 was granted and assigned to Promentis Pharmaceuticals on April, 2017 by the United States Patent and Trademark Office. | 9630937 | April 25, 2017 | |||||||
Patent 10112897 was granted and assigned to Promentis Pharmaceuticals on October, 2018 by the United States Patent and Trademark Office. | 10112897 | October 30, 2018 | |||||||
Patent 9012674 was granted and assigned to Promentis Pharmaceuticals on April, 2015 by the United States Patent and Trademark Office. | 9012674 | April 21, 2015 | |||||||
Patent 8815905 was granted and assigned to Promentis Pharmaceuticals on August, 2014 by the United States Patent and Trademark Office. | 8815905 | August 26, 2014 | |||||||
Patent 9193681 was granted and assigned to Promentis Pharmaceuticals on November, 2015 by the United States Patent and Trademark Office. | 9193681 | November 24, 2015 |